Effect of acetaminophen alone and in combination with morphine and tramadol on the minimum alveolar concentration of isoflurane in rats

PLoS ONE

Volumn 10, Issue 11, 2015, Pages

  Chavez, Julio R ^a   Ibancovichi, José A ^a   Sanchez Aparicio, Pedro ^a   Acevedo Arcique, Carlos M ^b   Moran Muñoz, Rafael ^a   Recillas Morales, Sergio ^a  

^a UNIVERSIDAD AUTÓNOMA DEL ESTADO DE MÉXICO   (Mexico)

^b UNIVERSIDAD AUTÓNOMA DE YUCATÁN   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

ISOFLURANE; MORPHINE SULFATE; PARACETAMOL; TRAMADOL; BIOLOGICAL MARKER; MORPHINE;

ANESTHESIA INDUCTION; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG POTENTIATION; ENDOTRACHEAL INTUBATION; MALE; MINIMUM LUNG ALVEOLUS CONCENTRATION; NOCICEPTIVE STIMULATION; NONHUMAN; RAT; WISTAR RAT; ANIMAL; COMBINATION DRUG THERAPY; DRUG EFFECTS; DRUG INTERACTION; LUNG ALVEOLUS; METABOLISM;

ACETAMINOPHEN; ANIMALS; BIOMARKERS; DRUG INTERACTIONS; DRUG THERAPY, COMBINATION; ISOFLURANE; MALE; MORPHINE; PULMONARY ALVEOLI; RATS; TRAMADOL;

EID: 84955449406     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0143710     Document Type: Article

References (41)

1. Jahr JS, Lee VK. Intravenous acetaminophen. Anesthesiol Clin. 2010; 28: 619-645. doi: 10.1016/j.anclin.2010.08.006 PMID: 21074742
2. Bebenista MJ, Nowak JZ. Paracetamol: mechanism of action, applications and safety concern. Acta Pol Pharm. 2014; 71: 11-23. PMID: 24779190
3. Vane JR. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nature. 1971; 231: 232-235.
4. Flower RJ, Vane JR. Inhibition of prostaglandin synthetase in brain explains the anti-pyretic activity of paracetamol (4-acetamidophenol). Nature. 1972; 240: 410-411. PMID: 4564318
5. Chandrasekharan NV, Dai H, Roos LT, Evanson NK, Tomsik J, Elton TS, et al. COX-3, a cyclooxygenase- 1 variant inhibited by acetaminophen and other analgesic/antipyretic drugs: cloning, structure, and expression. Proc Natl Acad Sci U S A. 2002; 99:13926-13931. PMID: 12242329
6. Kis B, Snipes JA, Busija DW. Acetaminophen and the cyclooxygenase-3 puzzle: sorting out facts, fictions, and uncertainties. J Pharmacol Exp Ther 2005; 315: 1-7. PMID: 15879007
7. Botting RM. Inhibitors of cyclooxygenases: mechanism, selectivity and uses. J Physiol Pharmacol. 2006; 57: 113-124. PMID: 17218763
8. Hinz B, Cheremina O, Brune K. Acetaminophen (paracetamol) is a selective cyclooxygenase-2 inhibitor in man. FASEB J. 2008; 22: 383-390. PMID: 17884974
9. Bjornsson GA, Haanaes HR, Skoglund LA. A randomized, double-blind crossover trial of paracetamol 1000 mg four times daily vs ibuprofen 600 mg: effect on swelling and other postoperative events after third molar surgery. Br J Clin Pharmacol. 2003; 55: 405-412. PMID: 12680890
10. Graham GG, Scott KF. Mechanism of action of paracetamol and related analgesics. Inflammopharmacology. 2003; 11: 401-413. PMID: 15035793
11. Högestätt ED, Jönsson BAG, Ermund A, Andersson DA, Björk H, Alexander JP, et al. Conversion of acetaminophen to the bioactive N-acylphenolamine AM404 via fatty acid amide hydrolase-dependent arachidonic acid conjugation in the nervous system. J Biol Chem. 2005; 280: 31405-31412. PMID: 15987694
12. Bertolini A, Ferrari A, Ottani A, Guerzoni S, Tacchi R, Leone S. Paracetamol: new vistas of an old drug. CNS Drug Rev. 2006; 12: 250-275. PMID: 17227290
13. Alloui A, Chassaing C, Schmidt J, Ardid D, Dubray C, Cloarec A, et al. Paracetamol exerts a spinal, tropisetron- reversible, antinociceptive effect in an inflammatory pain model in rats. Eur J Pharmacol. 2002; 443: 71-77. PMID: 12044794
14. Nakamura K, Li YQ, Kaneko T, Katoh, Negishi M. Prostaglandin EP3 receptor protein in serotonin and catecholamine cell groups: a double immunofluorescence study in the rat brain. Neuroscience. 2001; 103: 763-775. PMID: 11274793
15. Smith HS. Potential analgesic mechanisms of acetaminophen. Pain Physician. 2009; 12: 269-280. PMID: 19165309
16. Pini LA, Vitale G, Ottani A, Sandrini M. Naloxone-reversible antinociception by paracetamol in the rat. J Pharmacol Exp Ther. 1997; 280: 934-940. PMID: 9023309
17. Bujalska M. Effect of nitric oxide synthase inhibition on antinociceptive action of different doses of acetaminophen. Pol J Pharmacol. 2004; 56: 605-610. PMID: 15591650
18. Beaver WT. Combination analgesics. Am J Med. 1984; 10: 38-53.
19. Cobby TF, Crighton IM, Kyriakides K, Hobbs GJ. Rectal paracetamol has a significant morphine-sparing effect after hysterectomy. Br J Anaesth. 1999; 83: 253-256. PMID: 10618939
20. Delbos A, Boccard E. The morphine-sparing effect of propacetamol in the orthopedic postoperative pain. J Pain Symptom Manage. 1995; 10: 279-286. PMID: 7541435
21. Gómez de Segura IA, Criado AB, Santos M, Tendillo FJ. Aspirin synergistically potentiates isoflurane minimum alveolar concentration reduction produced by morphine in the rat. Anesthesiology. 1998; 89: 1489-1494. PMID: 9856724
22. Quasha AL, Eger EI, Tinker JH. Determination and applications of MAC. Anesthesiology. 1980; 53: 314-334.
23. Docquier MA, Lavand'homme P, Ledermann C, Collet V, De Kock M. Can determining the minimum alveolar anesthetic concentration of volatile anesthetic be used as an objective tool to assess antinociception in animals? Anesth Analg. 2003; 97: 1033-1039. PMID: 14500153
24. Remy C, Marret E, Bonnet F. Effects of acetaminophen on morphine side-effects and consumption after major surgery: meta-analysis of randomized controlled trials. Br J Anaesth. 2005; 94: 505-513. PMID: 15681586
25. Lewis Kelly S, Han Nina H. Tramadol: a new centrally acting analgesic. Am J Health Syst Pharm. 1997; 54: 643-652. PMID: 9075493
26. Dhillon S. Tramadol/paracetamol fixed-dose combination. Clin Drug Invest. 2010; 30: 711-738.
27. Schug SA. Combination analgesia in 2005 - a rational approach: focus on paracetamol-tramadol. Clin Rheumatol. 2006; 25: 16-21.
28. Alfano G, Grieco M, Forino A, Meglio G, Pace MC, Iannotti M. Analgesia with paracetamol/tramadol vs. paracetamol/codeine in one day-surgery: a randomized open study. Eur Rev Med Pharmacol Sci. 2011; 15: 205-210. PMID: 21434488
29. Criado AB, Gómez de Segura IA. Reduction of isoflurane MAC by fentanyl or remifentanil in rats. Vet Anaesth Analg. 2003; 30: 250-256. PMID: 12925182
30. Eger EI, Saidman LJ, Brandstater B. Minimum alveolar anesthetic concentration: a standard of anesthetic potency. Anesthesiology. 1965; 26: 756-763. PMID: 5844267
31. De Wolff MH, Leather HA, Wouters PF. Effects of tramadol on minimum alveolar concentration (MAC) of isoflurane in rats. Br J Anaesth. 1999; 83: 780-783. PMID: 10690143
32. Benito J, Aguado D, Abreu MB, García-Fernandez J, Gómez de Segura IA. Remifentanil and cyclooxygenase inhibitors interactions in the minimum alveolar concentration of sevoflurane in the rat. Br J Anaesth. 2010; 105: 810-817. doi: 10.1093/bja/aeq241 PMID: 20861096
33. Gutierrez-Blanco E, Victoria-Mora JM, Ibancovichi-Camarillo JA, Sauri-Arceo CH, Bolio-González ME, Acevedo.-Arcique CM, Marin-Cano G, Steagall PV. Evaluation of the isoflurane-sparing effects of fentanyl, lidocaine, ketamine, dexmedetomidine, or the combination lidocaine-ketamine-dexmedetomidine during ovariohysterectomy in dogs. Vet Anaesth Analg. 2013; 40: 599-609. doi: 10.1111/vaa.12079 PMID: 23910822
34. Knych HK, Steffey EP, Mama KR, Stanley SD. Effects of high plasma fentanyl concentrations on minimum alveolar concentration of isoflurane in horses. Am J Vet Res. 2009; 70: 1193-1200. doi: 10.2460/ajvr.70.10.1193 PMID: 19795933
35. Steagall PV, Teixeira Neto FJ, Minto BW, Campagnol D, Corrêa M. Evaluation of the isoflurane-sparing effects of lidocaine and fentanyl during surgery in dogs. J Am Vet Med Assoc. 2006; 229: 522-527. PMID: 16910849
36. Turner PV, Kerr CL, Healy AJ, Taylor WM. Effect of meloxicam and butorphanol on minimum alveolar concentration of isoflurane in rabbits. Am J Vet Res. 2006; 67: 770-774. PMID: 16649908
37. Vaughan CW, Ingram SL, Connor MA, Christie MJ. How opioids inhibit GABA-mediated neurotransmission. Nature. 1997; 390: 611-614. PMID: 9403690
38. Vaughan CW. Enhancement of opioid inhibition of GABAergic synaptic transmission by cyclo-oxygenase inhibitors in rat periaqueductal grey neurons. Br J Pharmacol. 1998; 123: 1479-1481. PMID: 9605550
39. Yamashita K, Okano Y, Yamashita M, Umar MA, Kushiro T, Muir WW. Effects of Carprofen and Meloxicam with or without butorphanol on the minimum alveolar concentration of sevoflurane in dogs. J Vet Med Sci. 2008; 70: 29-35. PMID: 18250569
40. Santos M, Kunkar V, García-Iturralde P, Tendillo FJ. Meloxicam, a specific COX-2 inhibitor, does not enhance the isoflurane minimum alveolar concentration reduction produced by morphine in the rat. Anesth Analg. 2004; 98: 359-363. PMID: 14742370
41. Doherty TJ, Will WA, Rohrbach BW, Geiser DR. Effect of morphine and flunixin meglumnie on isoflurane minimum alveolar concentration in goats. Vet Anaesth Analg. 2004; 31: 97-101. PMID: 15053747